OCONNELL DANIEL JOSEPH (President and CEO) sold 1.3% of their position (12.04K shares) of ACUMEN PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $22.0K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/23/2026ACC: 0001628280-26-003346
DirectorOfficer· President and CEO
Since Jun 2021
-12.04K
Net shares
Net seller
$22.0K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
12.04K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−9.35K
Price / share
$1.81
Trade value
$16.93K
% of position
1.0%
1/21/2026
893.31K→883.96K
Common Stock
Direct
Shares
−2.69K
Price / share
$1.88
Trade value
$5.07K
% of position
0.3%
1/22/2026
883.96K→881.27K
Total
Net shares
−12.04K
Net value
-$21.99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/21/2026 | S · Sale | −9.35K | $1.81 | $16.93K | 1.0% | 893.31K | 883.96K |
| Common Stock Direct | 1/22/2026 | S · Sale | −2.69K | $1.88 | $5.07K | 0.3% | 883.96K | 881.27K |
| Total | −12.04K | -$21.99K | ||||||
Derivative Transactions0
No derivative transactions reported